These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3107872

  • 21. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H, Quentin C, de Barbeyrac B, Bebear C.
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [Abstract] [Full Text] [Related]

  • 22. In vitro activity of five new quinolones against cultivable mycobacteria.
    Pattyn SR, Van Caekenberghe DL, Verhoeven JR.
    Eur J Clin Microbiol; 1987 Oct; 6(5):572-3. PubMed ID: 3125049
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
    Jones RN, Barrett MS, Erwin ME, Briggs BM, Johnson DM.
    Diagn Microbiol Infect Dis; 1991 Oct; 14(4):319-30. PubMed ID: 1909615
    [Abstract] [Full Text] [Related]

  • 26. Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.
    Chantot JF, Bryskier A.
    J Antimicrob Chemother; 1985 Oct; 16(4):475-84. PubMed ID: 3864775
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM, Baltch AL, Smith RP.
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [Abstract] [Full Text] [Related]

  • 29. In-vitro activity of fleroxacin.
    Georgopoulos A, Breyer S, Georgopoulos M, Mailer H, Graninger W.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():25-9. PubMed ID: 3144544
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.
    Akaniro JC, Vidaurre CE, Stutman HR, Marks MI.
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1880-4. PubMed ID: 2127170
    [Abstract] [Full Text] [Related]

  • 32. [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
    Grimm H.
    Infection; 1986 Oct; 14 Suppl 3():S191-5. PubMed ID: 3093387
    [Abstract] [Full Text] [Related]

  • 33. [Multicenter study of the activity of pefloxacin on bacteria isolated in a hospital milieu].
    Soussy CJ, Acar JF, Bergogne-Berezin E, Christol D, Courtieu AL, Duval J, Fleurette J, Lareng MB, Morel C, Thabaut A.
    Rev Med Interne; 1986 Mar; 7(2):197-204. PubMed ID: 3459222
    [Abstract] [Full Text] [Related]

  • 34. In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
    Wise R, Andrews JM, Ashby JP, Matthews RS.
    Antimicrob Agents Chemother; 1988 May; 32(5):617-22. PubMed ID: 3134843
    [Abstract] [Full Text] [Related]

  • 35. The comparative in-vitro activity of ofloxacin.
    Grüneberg RN, Felmingham D, O'Hare MD, Robbins MJ, Perry K, Wall RA, Ridgway GL.
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():9-19. PubMed ID: 3182468
    [Abstract] [Full Text] [Related]

  • 36. [Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
    Dabernat H, Delmas C, Lareng MB.
    Pathol Biol (Paris); 1985 May; 33(5):385-8. PubMed ID: 3162140
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.
    Hirai K, Aoyama H, Hosaka M, Oomori Y, Niwata Y, Suzue S, Irikura T.
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1059-66. PubMed ID: 2942103
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.